AXR vs WELL

For growth investors, Welltower Inc.

(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus -3. 3% for AMREP Corporation (AXR). AMREP Corporation (AXR) offers the better valuation at 11. 3x trailing P/E (12. 7x forward), making it the more compelling value choice. Analysts rate AMREP Corporation (AXR) a "Buy" — based on 1 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, AMREP Corporation (AXR) is the cheapest at 11.

3x versus Welltower Inc. at 153. 3x. On forward P/E, AMREP Corporation is actually cheaper at 12. 7x.

Over the past 5 years, Welltower Inc.

(WELL) delivered a total return of +202. 3%, compared to +141. 3% for AMREP Corporation (AXR). Over 10 years, the gap is even starker: AXR returned +504. 5% versus WELL's +223. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Welltower Inc.

(WELL) is the lower-risk stock at 0. 13β versus AMREP Corporation's 1. 02β — meaning AXR is approximately 664% more volatile than WELL relative to the S&P 500. On balance sheet safety, AMREP Corporation (AXR) carries a lower debt/equity ratio of 0% versus 49% for Welltower Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Welltower Inc.

(WELL) is pulling ahead at 35. 8% versus -3. 3% for AMREP Corporation (AXR). On earnings-per-share growth, the picture is similar: AMREP Corporation grew EPS 89. 6% year-over-year, compared to -11. 5% for Welltower Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

AMREP Corporation (AXR) is the more profitable company, earning 25.

6% net margin versus 8. 8% for Welltower Inc. — meaning it keeps 25. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AXR leads at 24. 4% versus 3. 3% for WELL. At the gross margin level — before operating expenses — AXR leads at 66. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, AMREP Corporation (AXR) trades at 12.

7x forward P/E versus 78. 4x for Welltower Inc. — 65. 7x cheaper on a one-year earnings basis.

In this comparison, WELL (1.

3% yield) pays a dividend. AXR does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Welltower Inc.

(WELL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 13), 1. 3% yield, +223. 1% 10Y return). Both have compounded well over 10 years (WELL: +223. 1%, AXR: +504. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: AXR is a small-cap deep-value stock; WELL is a mid-cap high-growth stock. WELL pays a dividend while AXR does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.